Thirty-six pigs (22 kg of BW) were used to evaluate a carbohydrase preparation, with xylanase and β-glucanase as main activities, added to either wheat-barley-rye- (WBR) or corn-based diets on performance, intestinal environment, and nutrient digestibility. Pigs were offered 1 of 4 different dietary treatments for 27 d according to a factorial arrangement of treatments (a 2 × 2) with 2 cereal types (WBR or corn) and 2 levels of supplemental carbohydrase (0 or 0.01%). Pig growth and feed intake were individually measured every week until the end of the experiment when pigs were slaughtered to obtain samples of digesta and tissues. Cereal type affected performance only during wk 1, in which WBR improved ADG (590 vs. 440 g/d; P = 0.008) and G:F (0.61 vs. 0.43; P = 0.045) compared with corn. The WBR also increased the viscosity of the digestive contents in stomach (1.95 vs. 1.23 mPa·s; P = 0.001) and ileum (6.53 vs. 2.80 mPa·s; P = 0.001) and resulted in greater cecal starch digestibility (95.7 vs. 93.9%; P = 0.012). However, trends for a reduction in digestibility were observed for glucose in the nonstarch polysaccharide (NSP) fraction in the ileum (64.4 vs. 75.8%; P = 0.074) and galactose in the NSP fraction in the cecum (1.4 vs. 1.8%; P = 0.055). The use of the enzyme preparation increased ADFI during wk 2 (1,328 vs. 1,215 g/d; P = 0.028), and increased villus height (423 vs. 390 µm; P = 0.045) and tended to reduce relative pancreas weight (0.16 vs. 0.17% BW; P = 0.079) at d 27. The enzyme also improved cecal starch digestibility (95.5 vs. 94.1%; P = 0.043) and tended to improve ileal energy digestibility (61.3 vs. 53.7%; P = 0.090) and cecal glucose digestibility in the NSP fraction (76.0 vs. 54.5%; P = 0.055). However, it reduced the cecal digestibility of mannose in the NSP fraction (27.0 vs. 50.5%; P = 0.016). Interactions (P < 0.05) between cereal type and enzyme supplementation were observed for ADG and G:F during wk 2, BW and ADG during wk 3, and BW and ADFI over the whole trial; and also for villus-height-to-crypt-depth ratio and for cecal DM digestibility. In all instances, whereas the added enzyme had no effect in the case of the corn diet, improvements were observed with WBR. In conclusion, the multi-enzyme tested had different effects depending on the type of cereal present in the diet.

Background: Faecal microbiota transplantation (FMT) is a novel potential therapy for inflammatory bowel diseases, but it is poorly characterised. Methods: We evaluated the performance of the mouse and rat as a pre-clinical model for human microbiota engraftment. We then characterised the effect of a single human stool transfer (HST) on a humanised model of DSS-induced colitis. Colonic and faecal microbial communities were analysed using the 16S rRNA approach and clinical manifestations were assessed in a longitudinal setting. Findings: The microbial community of rats showed greater similarity to that of humans, while the microbiome of mice showed less similarity to that of humans. Moreover, rats captured more human microbial species than mice after a single HST. Using the rat model, we showed that HST compensated faecal dysbiosis by restoring alpha-diversity and by increasing the relative abundance of health-related microbial genera. To some extent, HST also modulated the microbial composition of colonic tissue. These faecal and colonic microbial communities alterations led to a relative restoration of colon length, and a significant decrease in both epithelium damage and disease severity. Remarkably, stopping inflammation by removing DSS before HST caused a faster and greater recovery of both microbiome and clinical manifestation features. Interpretation: Our results indicate that the rat outperforms the mouse as a model for human microbiota engraftment and show that the efficacy of HST can be enhanced when inflammation stimulation is withdrawn. Finally, our findings support a new therapeutic strategy based on the use FMT combined with anti-inflammatory drugs.

Background: The remission of Crohn's disease (CD) can be accomplished by faecal microbiota transplantation (FMT). However, this procedure has a low success rate, which could be attributed to mis-communication between recipient intestinal mucosa and donor microbiota. Methods: Here we used a human explant tissue model and an in vivo mouse model to examine changes in recipient intestinal mucosa upon contact with a faecal suspension (FS) obtained from a healthy donor. CD patients provided resected inflamed and non-inflamed mucosal tissues, whereas control colonic mucosa samples were collected from colorectal cancer patients. For the models, mucosal microbiome composition and tissue response were evaluated. Findings: We show that cytokine release and tissue damage were significantly greater in inflamed compared to non-inflamed CD tissues. Moreover, mucosal samples harbouring an initial low microbial load presented a shift in composition towards that of the FS, an increase in the relative count of Faecalibacterium prausnitzii, and a higher secretion of anti-inflammatory cytokine IL-10 compared to those with a high microbial load. Interpretation: Our results indicate that FMT during active inflammatory disease can compromise treatment outcome. We recommend the stratification of FMT recipients on the basis of tissue microbial load as a strategy to ensure successful colonization. Funding: This study was supported by grants from the Instituto de Salud Carlos III/FEDER (PI17/00614), the European Commission: (INCOMED-267128) and PERIS (SLT002/16). K.M. is a postdoctoral fellow and S.V. a senior clinical investigator of the Fund for Scientific Research Flanders, Belgium (FWO-Vlaanderen).

The main objective of this work was to investigate the potential of a microencapsulated mixture of organic acids (formic and lactic acid) added to the feed of fattening pigs to reduce the prevalence and shedding of Salmonella when arriving to the abattoir. Two trials were performed. In Trial 1, 24 fattening pigs received one of three diets: a control diet, the same diet including lactic and formic acid (0.4% each) (non-protected blend; NPB), or a lipid microencapsulated blend (0.14% each acid) (protected blend; PB). After 10 days, digesta samples from various parts of gastrointestinal tract were taken. No changes were detected either in pH, total short chain fatty acids (SCFA), lactic/formic acid concentrations in any of the sections studied or in caecal lactic acid bacteria or enterobacteria. In Trial 2, 261 pigs from a commercial farm were distributed between the three previous diets in the five weeks before slaughtering. At the abattoir, no change was detected in caecal pH, but increased concentrations (p < 0.05) of formic and lactic acid were found with the NPB and PB treatments. The total SCFA concentration was higher with the PB compared to the control diet (p = 0.002) with a lower percentage of branched chain fatty acids. Both acidified diets decreased enterobacteria in the caecum but did not modify lactobacilli. NPB treatment decreased Salmonella seroprevalence (p < 0.001). A significant (p < 0.05) increase in Salmonella faecal shedding was found related to the stress previous to slaughter with the control group and PB, but not in the NPB group. More studies will be needed to confirm the usefulness of protected acids to prevent Salmonella prevalence and shedding at the abattoir.